Name: Pelthos Therapeutics Inc. (PTHS) Financial Statements
Creator: FinSpry

Pelthos Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Pelthos Therapeutics Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.20
Cost of Revenue	0.00	0.00	0.39	0.21	0.14
Gross Profit	0.00	0.00	-0.39	-0.21	0.06
Operating Expenses
Research & Development	1.18	2.58	0.39	0.21	0.00
Selling, General & Administrative	6.39	4.28	1.93	0.63	1.42
Operating Expenses	7.57	6.86	1.93	0.63	1.42
Operating Income	-7.57	-6.86	-2.32	-0.84	-1.35
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.79	0.52	-0.14	0.00	0.00
Other Income/Expense	0.40	0.00	0.00	0.24	0.69
Income
Income Before Tax	-7.96	-7.38	-2.46	-0.60	-0.66
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-7.96	-7.38	-2.46	-0.60	-0.66
Net Income - Continuous Operations	-7.96	-7.38	-2.46	-0.60	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-7.17	-6.86	-1.63	-0.60	0.00
EBIT	-7.17	-6.86	-2.32	-0.84	-1.35
Depreciation & Amortization	0.00	0.00	0.69	0.00	0.00
Earnings Per Share
Basic EPS	-14.00	-13.00	-56.00	-1.00	-
Diluted EPS	-14.00	-13.00	-56.00	-1.00	-
Basic Shares Outstanding	0.56	0.58	0.04	0.58	0.00
Diluted Shares Outstanding	0.56	0.58	0.04	0.58	0.00